ZS REWARD: Advancing health care development for India – The Economic Times

< img alt

=”” width=” 300 “src=” https://img.etimg.com/thumb/msid-78997901,width-300,imgsize-46402,,resizemode-4,quality-100/640×480-1.jpg” > ET Spotlight India is home to some of the finest talents worldwide. The country has a prominence for ingenuity in developing inexpensive innovations. However, the healthcare sector has not been able to tap into this talent pool. The nation ranks badly on a number of healthcare indicators.

Non-communicable diseases such as diabetes, cancer, persistent respiratory diseases, and heart diseases represent 60 percent of India’s deaths. And this number is climbing up. The scarcity and bad healthcare facilities quality at the primary level continues and is a significant hurdle in rural and parts of city India. India’s war with Covid is extremely challenging due to the fact that of the comorbidities these health conditions trigger to infected persons and large absence of infrastructure.

It is against this background that ZS, a leading international professional services company, designed ZS REWARD to reward India’s healthcare development. The effort launched on October 28, 2020, looks for to welcome ingenious health care services that can have a countrywide impact for all. ZS REWARD intends to acknowledge, advance, and commemorate innovative, tech-enabled, unique healthcare solutions that can change India’s healthcare community.

Released on October 28, 2020, trainees and specialists can submit their concepts or service prototypes through December 21, 2020. The top 20 picked teams, examined on pre-defined requirements, will go through a six-week mentorship with ZS leaders between January and February 2021. The top 8 groups out of the 20 will then present their services to the Jury in March 2021, and the winners revealed in April 2021.

Speaking at the launch of ZS PRIZE, Sanjay Joshi, Regional managing principal and head of Asia at ZS, said,
We are launching ZS REWARD with the particular focus of advancing health care innovation in India. We desire to reward health care innovations that do the best good to millions of Indians.”


Joshi included that due to today’s environment, when the one issue controling all conversations is health and healthcare, we want to provide a program to Indian residents wherein they can come together to fix Indias’ health care challenges.

ZS PRIZE means to become a driver for trainees, working specialists from NGOs, start-ups, and business by assisting them change their ideas into a fully functioning option. To facilitate this even more, ZS will help the leading 20 shortlisted teams go through a 6-week integrated mentorship program.

Why participate

Winners of the coveted ZS PRIZE will have to have a leader’s idea procedure and create tangible services that will affect millions of lives. Being shortlisted or winning ZS Prize will help the individuals and teams to reach out to the larger community at stake, and effect their lives, resulting in a much better Indian health care ecosystem.

Aside from Rs 1 crore cash prize, winners will access to the deep expertise from the built-in mentorship program by ZS leadership. They will also get a possibility to display their options to the noteworthy Jury that boasts some of the greatest nationwide and global names from the healthcare and tech industries. Together with this, the winning team/teams will get the once in a life time chance to fix for India. The nationwide acknowledgment and honour of winning the desirable ZS Prize will be additional.

Screenshot 2020-11-02 at 4.22.50 PM< img title =" Screenshot 2020-11-02 at 4.22.50 PM" alt =" Screenshot 2020-11-02 at 4.22.50 PM" src =" https://img.etimg.com/photo/msid-78999153,quality-100/screenshot-2020-11-02-at-4-22-50-pm.jpg" data-msid =" 78999153"

> ET Spotlight Noteworthy Jury of ZS REWARD An eight-member Jury with Ravi Venkatesan as Chairman will decide the winners in March 2021. The Jury consists of Kiran Mazumdar Shaw, Executive Chairperson of Biocon, Sangita Reddy, Joint Managing Director of Apollo Hospitals, Dr. Dipak Jain, President (European) and Professor, CEIBS, Vijay Chandru Reddy, Creator of Strand Life Sciences, Sandeep Singhal, Co-founder and Managing Director of Nexus Endeavor Partners, Prof K Srinath Reddy, President Public Health Structure of India and Dr. Ferzaan Engineer, Co-founder, and Chairman of Cytecare Hospitals.

When sharing the appeal of ZS REWARD and why he gladly took on the function of Chairman of the Jury, Ravi Venkatesan confessed
, ” Our only hope of really getting to a much better place is to significantly increase the variety of individuals who are dealing with these problems. ZS REWARD has the chance, to make this distinction in health care, initially in India then in other parts of the world.”

When speaking of the goals for ZS PRIZE, Venkatesan said,
” We wish to determine a small number of people whom we believe have the prospective to do fantastic work. We desire the jury members and the individuals to have a great time in this procedure. You understand my fellow jury members are extraordinary, extremely achieved people, and they’re offering a substantial quantity of their time. And I hope that the ZS PRIZE process gets them thrilled. I hope the Jury and participants take pleasure in meeting, and the applicants get to find out and form relationships with these eminent individuals. I believe if we can do this, and that permits us next year to do even much better, it would be wonderful stuff.”



You can enjoy unique interviews of the Jury and understand more about ZS PRIZE at
https://zsprize.zs.com/. The Jury has actually gone over the problems looking for services, their expectations of the entries, and more.

ZS PRIZE is supported by The Economic Times and TechGig.

( This article is created and released by ET Spotlight group. You can get in touch with them on [email protected]).